|
|
||||||||
Original Articles |
Although home recording of peak expiratory flow (PEF) is considered useful in managing asthma, little is known about the relationship of PEF variation to other indicators of disease activity. We examined the relationship of PEF variation, expressed in various ways, to symptoms, atopy, level of lung function, and airways hyperresponsiveness in schoolchildren with asthma. One hundred and two asthmatic children (aged 7-14 yrs) recorded symptoms and PEF (twice daily) in a diary for 2 weeks after withdrawal of all anti-inflammatory maintenance medication. PEF variation was expressed as amplitude % mean, as standard deviation and coefficient of variation of all recordings, and as low % best (lowest PEF as percentage of the highest of all values). Atopy and level of forced expiratory volume in one second (FEV1) % predicted were not significantly related to PEF variation. The provocative dose of histamine causing a 20% fall in FEV1 (PD20) and symptom scores were significantly, but weakly, related to PEF variation. The index, low % best, proved easy to calculate and effective in identifying a short-term episode of reduced PEF. We conclude that peak expiratory flow variation in children with stable, moderately severe asthma is significantly, but weakly, related to symptoms and airways hyperresponsiveness. These three phenomena, therefore, all provide different information on the actual disease state. Expressing peak expiratory flow variation as low % best is easy to perform and appears to be clinically relevant.
This article has been cited by other articles:
![]() |
A. F. J. Brouwer, R. J. Roorda, E. J. Duiverman, and P. L. P. Brand Reference values for peak flow and FEV1 variation in healthy schoolchildren using home spirometry Eur. Respir. J., November 1, 2008; 32(5): 1262 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. J. Brouwer, R. J. Roorda, and P. L. P. Brand Home spirometry and asthma severity in children Eur. Respir. J., December 1, 2006; 28(6): 1131 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. VISSER, D. S. POSTMA, L. R. ARENDS, T. W. DE VRIES, E. J. DUIVERMAN, and P. L. P. BRAND One-Year Treatment with Different Dosing Schedules of Fluticasone Propionate in Childhood Asthma . Effects on Hyperresponsiveness, Lung Function, and Height Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2073 - 2077. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.D. Leuppi, C.M. Salome, C.R. Jenkins, H. Koskela, J.D. Brannan, S.D. Anderson, M. Andersson, H.K. Chan, and A.J. Woolcock Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Eur. Respir. J., September 1, 2001; 18(3): 444 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. ALMQVIST, M. WICKMAN, L. PERFETTI, N. BERGLIND, A. RENSTROM, M. HEDREN, K. LARSSON, G. HEDLIN, and P. MALMBERG Worsening of Asthma in Children Allergic to Cats, after Indirect Exposure to Cat at School Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 694 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D SLY and F. FLACK Is home monitoring of lung function worthwhile for children with asthma? Thorax, March 1, 2001; 56(3): 164 - 165. [Full Text] |
||||
![]() |
J. D. LEUPPI, C. M. SALOME, C. R. JENKINS, S. D. ANDERSON, W. XUAN, G. B. MARKS, H. KOSKELA, J. D. BRANNAN, R. FREED, M. ANDERSSON, et al. Predictive Markers of Asthma Exacerbation during Stepwise Dose Reduction of Inhaled Corticosteroids Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 406 - 412. [Abstract] [Full Text] |
||||
![]() |
H. Reddel, C. Jenkins, and A. Woolcock Diurnal variability---time to change asthma guidelines? BMJ, July 3, 1999; 319(7201): 45 - 47. [Full Text] |
||||
![]() |
P. L P Brand, E. J Duiverman, H. J Waalkens, E. E M van Essen-Zandvliet, K. F Kerrebijn, and the Dutch CNSLD Study Group Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long term treatment with inhaled corticosteroids Thorax, February 1, 1999; 54(2): 103 - 107. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |